- Company Overview for COVID BIOPHARMA LIMITED (12570359)
- Filing history for COVID BIOPHARMA LIMITED (12570359)
- People for COVID BIOPHARMA LIMITED (12570359)
- More for COVID BIOPHARMA LIMITED (12570359)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
26 Sep 2024 | AA | Accounts for a dormant company made up to 31 December 2023 | |
02 May 2024 | CS01 | Confirmation statement made on 22 April 2024 with updates | |
29 Sep 2023 | AA | Accounts for a dormant company made up to 31 December 2022 | |
24 Apr 2023 | PSC04 | Change of details for Mr Peter Kadas as a person with significant control on 24 April 2023 | |
24 Apr 2023 | CH01 | Director's details changed for Mr Gabor Istvan Illes on 24 April 2023 | |
24 Apr 2023 | CH01 | Director's details changed for Mr Daniel Arthur Hallgarten on 24 April 2023 | |
24 Apr 2023 | AD01 | Registered office address changed from 85 Great Portland Street, First Floor London W1W 7LT United Kingdom to 1st Floor 40-44 Newman Street London W1T 1QD on 24 April 2023 | |
22 Apr 2023 | PSC04 | Change of details for Mr Peter Kadas as a person with significant control on 22 April 2023 | |
22 Apr 2023 | CS01 | Confirmation statement made on 22 April 2023 with updates | |
19 Oct 2022 | CH01 | Director's details changed for Mr Daniel Arthur Hallgarten on 18 October 2022 | |
20 Sep 2022 | AA | Accounts for a dormant company made up to 31 December 2021 | |
05 May 2022 | CS01 | Confirmation statement made on 22 April 2022 with updates | |
14 Sep 2021 | AA | Accounts for a dormant company made up to 31 December 2020 | |
29 Apr 2021 | CS01 | Confirmation statement made on 22 April 2021 with updates | |
16 Dec 2020 | AA01 | Current accounting period shortened from 30 April 2021 to 31 December 2020 | |
16 Dec 2020 | TM01 | Termination of appointment of Eniko Toke as a director on 15 December 2020 | |
16 Dec 2020 | TM01 | Termination of appointment of Peter Kadas as a director on 15 December 2020 | |
16 Dec 2020 | TM01 | Termination of appointment of Christopher Gallen as a director on 15 December 2020 | |
23 Apr 2020 | NEWINC |
Incorporation
Statement of capital on 2020-04-23
|